AIM
MDT icon

Acrospire Investment Management’s Medtronic MDT Stock Holding History

Acrospire Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,525
Closed -$224K – 844
2017
Q2 		$224K Buy
2,525
+2,000
+381% +$169K 0.21% 15
2017
Q1 		$42K Sell
525
-200
-28% -$15.6K 0.03% 1101
2016
Q4 		$52K Buy
725
+700
+2,800% +$55K 0.02% 1381
2016
Q3 		$2K Buy
+25
New +$2.18K ﹤0.01% 1912

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Acrospire Investment Management's MDT Position: Q3 2017 in Review

Acrospire Investment Management sold out of Medtronic (MDT) in Q3 2017, closing a stake of 2,525 shares — an estimated $224K sold.

Acrospire Investment Management first reported a position in MDT in Q3 2016 and held it in 4 quarters. The position peaked at $224K in Q2 2017. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

  • Acrospire Investment Management reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2,525 Medtronic shares in Q3 2017, an estimated $224K.
  • Acrospire Investment Management first reported a position in Medtronic in Q3 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Medtronic position peaked at $224K in Q2 2017.
  • 1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.